How to Estimate Pulmonary Artery Pressure on Echo

Echocardiography estimates pulmonary artery systolic pressure (PASP) primarily by measuring the speed of a tricuspid regurgitation jet and adding an estimate of right atrial pressure. The method relies on a straightforward physical relationship between blood velocity and pressure, and in large studies it correlates well with invasive catheter measurements, though individual-level accuracy can vary enough to matter clinically. Beyond this core calculation, echo offers several complementary approaches for mean and diastolic pressures, pulmonary vascular resistance, and qualitative signs of elevated right heart pressures that together paint a fuller hemodynamic picture without threading a catheter.

The Core Calculation Using Tricuspid Regurgitation Velocity

Almost everyone has a tiny amount of tricuspid regurgitation (TR), where a small jet of blood leaks backward through the tricuspid valve during each heartbeat. That jet is the key to estimating pulmonary pressure. Using continuous-wave Doppler, the sonographer aligns the ultrasound beam with this jet and measures its peak velocity. A faster jet means a bigger pressure difference between the right ventricle and the right atrium. The simplified Bernoulli equation converts that velocity into a pressure gradient: you square the peak velocity and multiply by four. If the peak TR velocity is 3 m/s, for example, the gradient is 36 mmHg.

That gradient alone is not the full systolic pressure in the pulmonary artery. You still need to add right atrial pressure (RAP), because the gradient only tells you the difference between the right ventricle and the right atrium. PASP equals the gradient plus RAP. In a study of patients with chronic heart failure, this approach yielded PASP values ranging from 13 to 110 mmHg, and both systolic and diastolic estimates from the TR jet showed good agreement with invasive catheter measurements.¹ The TR velocity can also be combined with pulmonary flow acceleration time as an alternative route when one measurement is easier to obtain than the other.²

Estimating Right Atrial Pressure From the Inferior Vena Cava

Because the TR-based method needs a right atrial pressure value to complete the equation, getting that estimate right matters. The standard approach uses the inferior vena cava (IVC), the large vein that empties into the right atrium. You measure two things: the IVC’s diameter and how much it collapses when the patient sniffs. A small IVC that collapses briskly suggests low right atrial pressure (around 3 mmHg), while a dilated IVC that barely budges points to higher pressure (around 15 mmHg), with an intermediate category in between.

This IVC-based estimate is simple to perform and widely taught, but it introduces a meaningful source of error. A study of over 900 patients with congenital heart disease found that IVC collapsibility correlated well with invasive right atrial pressure, and that using a collapsibility cutoff below 60% outperformed the standard American Society of Echocardiography (ASE) criteria.³ In critically ill patients, IVC diameter and collapsibility remain a practical bedside tool for evaluating right heart performance, though conditions like mechanical ventilation and high intra-abdominal pressure can distort the measurements.⁴

In practice, the RAP estimate is the weakest link in the PASP calculation. Whether you assign 3, 8, or 15 mmHg changes your final number substantially. Many experienced echocardiographers treat the IVC estimate as a rough category rather than a precise measurement, and when the clinical stakes are high, they weigh other clues like hepatic vein flow patterns or simply note the uncertainty.

Mean and Diastolic Pulmonary Artery Pressure

Systolic pressure gets the most attention because it is the easiest to measure, but mean pulmonary artery pressure (mPAP) is what defines pulmonary hypertension in current guidelines: a mean above 20 mmHg at rest by catheter. Echo can estimate mPAP through a few routes. One validated approach uses pulmonary regurgitation (PR), the small backflow jet through the pulmonary valve. By measuring the peak velocity of that PR jet in early diastole and applying the Bernoulli equation, researchers found a strong correlation with invasively measured mean pulmonary pressure.⁵

The end-diastolic velocity of the same PR jet can estimate diastolic pulmonary artery pressure, again using Bernoulli with the addition of RAP. Having all three values (systolic, diastolic, and mean) is particularly helpful when trying to distinguish different causes of pulmonary hypertension. For instance, a patient whose systolic pressure is elevated but whose diastolic-to-systolic gradient is narrow may have a different hemodynamic profile than someone with a wide gradient. These distinctions guide whether the problem sits in the lungs, the left heart, or both.

Estimating Pulmonary Vascular Resistance

Pressure alone does not tell the whole story. Two patients can have the same pulmonary artery pressure but very different pulmonary vascular resistance (PVR), and PVR is what determines whether the small blood vessels in the lungs are diseased. Echo can estimate PVR by dividing the TR velocity by the velocity-time integral of the right ventricular outflow tract (RVOT) flow. In the original study validating this ratio, the correlation with catheter-measured PVR was very strong, and a cutoff ratio of 0.175 had roughly 77% sensitivity and 81% specificity for detecting resistance above 2 Wood units.⁶

That said, the accuracy of this ratio appears to depend on the patient population. In chronic thromboembolic pulmonary hypertension (CTEPH), a condition where old blood clots obstruct the pulmonary arteries, one study found only marginal agreement between the echo-derived PVR and catheter PVR, with the regression equation differing from what was established in other forms of pulmonary hypertension.⁷ A newer approach analyzes the timing of a notch in the RVOT Doppler tracing, specifically the ratio of notch time to ejection time, and in validation testing outperformed five established methods with a Pearson correlation of 0.76 against catheter PVR.⁸ This method is promising but not yet widely adopted.

When the TR Signal Is Weak

The entire PASP calculation depends on getting a clean, measurable TR jet, and that does not always happen. Some patients have such minimal regurgitation that the spectral Doppler envelope is faint or incomplete. When you cannot confidently identify the peak velocity, the number you derive is unreliable. This is one of the most common practical frustrations with the technique.

Agitated saline contrast, where you rapidly shake a saline syringe to create microbubbles and inject them intravenously, can enhance the Doppler signal. An early study showed that adding a small amount of blood to the saline mixture improved the correlation with catheter-measured PASP from 0.64 at baseline to 0.92 with the contrast.⁹ With modern scanners, commercially available contrast microspheres still add value when the unenhanced TR signal is absent or suboptimal, though patients who already have a clear TR envelope or more than mild regurgitation generally do not benefit from the extra step.¹⁰

The Problem With Severe Tricuspid Regurgitation

Paradoxically, the patients who have the most tricuspid regurgitation are sometimes the hardest to assess accurately. When TR is severe, the pressure in the right atrium rises substantially, and the gradient between the right ventricle and the right atrium may actually shrink even though pulmonary pressure remains high. This can lead to underestimation of the true PASP. In a study comparing echo and catheterization in patients referred for tricuspid valve intervention, overall correlation was good, but among the roughly one-third of patients with severe TR, the correlation weakened and echo tended to underestimate pressure.¹¹

This is a clinically important pitfall. A patient with severe TR and a seemingly modest PASP on echo may actually have much higher pulmonary pressures once you account for how elevated their right atrial pressure really is. In such cases, relying on the IVC-based RAP estimate becomes even more precarious, and clinicians often proceed to catheterization for a definitive answer.

How Echo Compares to Catheterization Overall

Right heart catheterization remains the gold standard for measuring pulmonary pressures, so every echo-based estimate is ultimately judged by how well it matches catheter data. In a large cohort study, Doppler-estimated PASP averaged about 45 mmHg compared to a catheter-measured average of about 47 mmHg, with a correlation coefficient of 0.87 and a small average underestimation of 2 mmHg. Sensitivity for diagnosing pulmonary hypertension was 87% and specificity was 79%.¹² Another study found 97% agreement between echo and catheter, though individual accuracy for any single patient was only about 43%, meaning the method works well for populations but can be off by a meaningful amount for any given person.¹³

The practical takeaway is that echo is an excellent screening and monitoring tool, but a single echo-derived number should not be treated as gospel. Limits of agreement on Bland-Altman analysis typically span a range of roughly plus or minus 15 to 18 mmHg from the catheter value, which means an echo estimate of 50 mmHg could correspond to a true pressure anywhere from the low 30s to the upper 60s. When the clinical question hinges on whether pressure is mildly or moderately elevated, that range matters, and catheterization may be needed to resolve the ambiguity.

Supporting Signs Beyond the Numbers

Experienced readers do not rely solely on the TR jet. Several qualitative and semi-quantitative findings help build the overall picture of whether pulmonary pressures are elevated:

Right ventricular dilation and dysfunction: A right ventricle that is larger than the left or contracts poorly suggests chronic pressure overload.
Septal flattening: The interventricular septum normally bows into the right ventricle. When right-sided pressures are elevated, the septum flattens or even bows into the left ventricle. In pediatric pulmonary hypertension, the eccentricity index at end-systole was significantly higher in patients with elevated pressures compared to controls.¹⁴
Right atrial enlargement: A stretched right atrium fits with chronically elevated filling pressures.
RVOT notching: A midsystolic notch in the pulmonary artery Doppler flow profile suggests high downstream resistance.
Short acceleration time: The time from the onset of RVOT flow to its peak velocity shortens as pulmonary pressure rises. An acceleration time under about 100 milliseconds raises suspicion.

Current European Society of Cardiology (ESC) guidelines use a probability-based system that combines the TR velocity with these supporting signs. In a real-world audit comparing the 2015 and 2022 ESC algorithms, the updated version classified about 58% of referred patients as high probability, with a sensitivity of 89% and specificity of 62%. Roughly one-third of patients classified as low probability still turned out to have confirmed pulmonary hypertension on catheterization, a reminder that a low-probability echo result does not entirely exclude the diagnosis.¹⁵

Stress Echocardiography and Exercise-Induced Pulmonary Hypertension

Some patients have normal pulmonary pressures at rest but develop abnormal pressure responses during exercise, a condition increasingly recognized as exercise-induced pulmonary hypertension. Rest-only echo will miss this entirely. Stress echocardiography, where the patient exercises on a bicycle or treadmill and images are obtained during or immediately after exertion, can unmask these latent hemodynamic abnormalities. This has implications for early detection of pulmonary vascular disease, prognosis in valvular heart disease, and diagnosis of heart failure with preserved ejection fraction.¹⁶

The challenge is that imaging during exercise is technically harder. The patient is moving, heart rate is fast, and acoustic windows shift. Despite these difficulties, studies in patients with chronic thromboembolic disease have shown that stress echo assessments of exercise systolic pressure and the mPAP-to-cardiac-output slope predicted exercise-induced pulmonary hypertension with good discrimination compared to invasive measurements during simultaneous catheterization.¹⁷ The use of semi-supine bicycle exercise, where the patient pedals while lying partly reclined on the echo bed, is generally preferred over treadmill because imaging can happen continuously during exertion rather than just after it.

Challenges in the ICU and on Mechanical Ventilation

Echo-based pressure estimation gets considerably trickier in critically ill patients on mechanical ventilators. Positive pressure ventilation alters intrathoracic pressures, distorts IVC dynamics, and changes the loading conditions of both ventricles. A study of mechanically ventilated patients found that using standard diastolic function guidelines to predict pulmonary artery occlusion pressure (a proxy for left atrial pressure) was indeterminate in nearly half of patients. Even among those who did get a definitive classification, sensitivity and specificity for detecting elevated pressures were both only about 74%. In the ICU, echo estimates should be interpreted alongside trends over time and other hemodynamic data rather than treated as standalone numbers.

Pediatric and Congenital Heart Disease Populations

Children and patients with congenital heart disease present unique challenges. The anatomy may be abnormal, with shunts, absent valves, or surgically altered connections that make standard adult algorithms inapplicable. A prospective study in children with congenital heart disease developed specialized equations for detecting elevated systolic, diastolic, and mean pulmonary pressures, using cutoffs tailored to the pediatric range. The equations achieved high sensitivity but only moderate specificity, and they tended to underestimate pressures at the higher end of the range, a pattern that parallels adult findings with severe TR.

The IVC-based RAP estimate also behaves differently in congenital heart disease. As described earlier, a study of over 900 such patients found that the standard ASE collapsibility cutoff of 50% was outperformed by a cutoff of 60%, suggesting that the normal ranges developed in adults may need recalibration for these patients.³ In practice, pediatric cardiologists tend to use echo as one piece of a multimodal assessment and have a lower threshold for catheterization when clinical decisions depend on precise pressure values.

Artificial Intelligence and Automated Measurements

One of the newer frontiers is using deep-learning algorithms to automate the measurements that go into pulmonary pressure estimation. A study evaluating an AI-based echocardiography system found no significant measurement bias for peak TR velocity, right atrial area, or tricuspid annular plane systolic excursion when compared to a core laboratory. For detecting pulmonary hypertension in a case-control setting, peak TR velocity measured by the AI system achieved an area under the curve of 0.98, nearly matching the 0.99 achieved by expert reads. Performance in a more real-world referral cohort was somewhat lower, with AUCs of 0.79 for clinical laboratory reads and 0.75 for the AI, a gap that did not reach statistical significance.¹⁸

The appeal of AI in this space is consistency and accessibility. Measuring TR velocity and IVC collapsibility are operator-dependent skills that vary with experience. If an algorithm can reliably identify and quantify the TR jet, it could make the technique more reproducible across sites, particularly in settings where expert sonographers are scarce. The technology is still early, and most labs use AI as a second reader rather than a replacement, but the trajectory is clearly toward greater automation of what has traditionally been a hands-on, skill-intensive assessment.